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Abstract 
Background: To identify etiologic factors   causing 
acute kidney injury (AKI) in our local population that 
were admitted to  tertiary care nephrology unit over one 
year duration. 
Methods:  In this prospective cohort study adult 
patients with elevated serum creatinine, evaluated at least 
twice,were  included. Workup for glomerulonephritis 
included complements levels, ANA, Anti dsDNA, 
ANCA,AntiGBM, SPEP. Renal biopsy was performed for 
suspected RPGN/Vasculitis, AIN, unexplained AKI.Renal 
replacement therapy was initiated for standard 
indications. Decreased renal perfusion was diagnosed 
when blood pressure was less than 90/60 mmHg, signs of 
volume depletion and severe cardiac failure. Urine output 
 less than 400ml/day was taken as oliguria. The AKI 
definition and diagnosis was based on RILFE criteria ,i.e, 
an abrupt (1 to 7 days) and sustained (more than 24 hours) 
decrease in kidney function.  
Results: Majority (62%) were male. Majority  of the 
patients  (87.1%) were in failure category. Infection/sepsis 
was the most common etiology (44.6 %), followed by drugs 
(10.5%),gastroenteritis (10.2%),surgical cases (8.8%) and  
obstructive nephropathy (7.5 %). Mortality was  39.1%, 
reflecting critical condition and markedly deranged renal 
function. 
Conclusion: AKI is a major public health challenge. It 
is associated with high morbidity and mortality. 
Infection/sepsis is the predominant etiological factor 
causing AKI in our patients. Combating 
infections/communicable diseases is crucial  in preventing 
AKI . 
Key Words: Acute Kidney Injury(AKI), Community 
acquired acute kidney injury (CAAKI), RILFE criteria . 
 
Introduction 
AKI is a universal medical issue with high morbidity 
and mortality. 1  AKI is associated with significantly 
increased morbidity, mortality, length of stay, and 
costs. 2,3. Statistics have shown the global burden of 
AKI  up to 13.3 million cases per year, 11.3 million of 
which are in low to middle income countries and is  
responsible for up to 1.4 million deaths per year.  AKI 
accounts for up to 3% of hospital admissions in 
developing countries.4 There is progressive increase in 
incidence of dialysis requiring AKI as well as non-
dialysis requiring AKI.5-8 Epidemiology of AKI differs 
significantly between high resource countries and low 
and   middle income countries  in the western 
hemisphere where education and training programs  
can increase the public awareness, improve preventive 
 strategies and management to improve  outcomes.9 
The prevalence, morbidity and mortality due to sepsis 
related AKI is very high in  underdeveloped 
countries.10 AKI has a major economic impact on 
healthcare  costs in  developing countries as it mostly 
affects young productive people causing severe  
financial hardship.11 Despite higher prevalence of AKI 
 in low income countries very limited data is available 
from them.12 Community acquired acute kidney injury 
(CAAKI) is a major problem in developing  countries 
and is markedly different from AKI in developed 
temperate climate countries because tropical 
diseases/infections are rife in hot and humid climate 
stricking the  already poor and marginalized 
populations.13 The International Society of Nephrology 
set a goal of eliminating preventable deaths from AKI 
by 2025, implementation of this program in less 
developed countries poses major challenges because of 
the lack of resources  and  scarce data regarding the 
epidemiology  of AKI, the limited  facilities to 
diagnose and treat AKI, and the poor awareness of the 
impact of AKI on patient outcomes.1 There is lack of 
accurate data of AKI in underdeveloped countries like 
Pakistan because of poor access to efficient medical 
facilities, poor recognition of the condition, high 
burden of infections, nephrotoxins including 
traditional herbal remedies, obstetric complications, 
natural disasters, late referral, non affordability,as well 
as poor documentation, underreporting and no central 
registry compiling national data.  
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Patients and Methods 
 In this prospective cohort study , performed in 
Department of Nephrology ,   patients   with elevated 
serum creatinine (evaluated twice), were included. 
Workup  for glomerulonephritis included complement 
levels, ANA, Anti dsDNA, ANCA,AntiGBM, SPEP. 
Renal biopsy was performed for suspected 
RPGN/Vasculitis, AIN, unexplained AKI and was sent 
for histopathology and immunofluoresence. Exclusion 
criteria were age less than 14 years, clinical, 
radiological or laboratory evidence of chronic kidney 
disease (CKD), disparity in renal sizes more than 2 cm, 
polycystic kidneys, previous history of haemodialysis, 
renal transplant, end stage renal disease (ESRD) and 
pregnant females. Decreased renal perfusion was 
diagnosed when BP was less than 90/60 mmHg, signs 
of volume depletion, severe cardiac failure. Sepsis was 
defined as a serious infection plus  ≥2  systemic 
inflammatory response syndrome criteria, including  
heart rate >90 beats/min, temperature >38.3 or <36°C), 
tachypnea (>20 breaths/min) or PCO 2  <32 mm Hg, 
and leukocytosis (white blood cells >12,000 or < 4,000 
cells/mm 3  or >10% band forms. Hypertension was 
defined as blood pressure above 140/90 mmHg.  
Urine output  less than 400ml/day, was  taken as 
oliguria.The AKI definition and diagnosis was based 
on RILFE criteria; an abrupt (1 to 7 days) and 
sustained (more than 24 hours) decrease in kidney 
function. RIFLE criteria consists of three graded levels 
of injury (Risk, Injury, and Failure based upon either 
the magnitude of elevation in serum creatinine or 
urine output reduction (the worst parameter was used 
to classify), and two outcome measures (Loss and End-
stage renal disease). The RIFLE is staged as  :Risk — 
1.5 fold increase in the serum creatinine or urine 
output <0.5 mL/kg per hour for six hours;Injury — 
Twofold increase in the serum creatinine or urine 
output <0.5 mL/kg per hour for 12 hour;Failure — 
Threefold increase in the serum creatinine or urine 
output of <0.3 mL/kg per hour for 24 hours, or anuria 
for 12 hours.14 Baseline serum creatinine was 
calculated using the modification of diet in renal 
disease MDRD) equation, assuming a baseline 
glomerular filtration (GFR) of 75 ml/min/1.73m2, as 
previous baseline renal functions tests were not 
available. Also creatinine trend in recovery phase 
helped to determine baseline creatine and helped in  
confirmation of AKI occurrence. 
 
Results 
Total 294 cases  with AKI, fulfilling the inclusion 
criteria were admitted during the study period (one 
year). Males constituted 62.6%. Renal-AKI accounted 
for  60.5 %. Infection/sepsis was the most common 
etiology(44.6 %) (Table 1). Drugs causing AKI were 
radio contrast agents ( 6 cases), aminoglycosides (5 
cases ),chemotherapeutics(4 cases), NSAIDs (3 
cases),acyclovir (3 cases),  amphotericin (1 case),  
unknown(traditional herbal) (2 cases). Combination of 
drugs (NSAIDs, ACE-1/ARBs, diuretics)causing AKI 
were responsible in 7 patients.  
 
Table 1: Patients demographic and 
 aetiology of ARF 
Total number of patients=  294 Frequency Percent 
Age Mean=46.3980; SD=19.49765,Min=13.00,Max=95.00 
< 25 years 60 20.4 
25 - 50 years 102 34.7 
51 - 75 years 115 39.1 
76 y 17 5.8 
Gender 
Male 184 62.6 
Female 110 37.4 
Category 
Prerenal 87 29.6 
Intrinsic/renal 178 60.5 
Postrenal/Obstruction 22 7.4 
Idiopathic 7 2.3 
Etiology 
Infection 131 44.6 
RPGN/acute GN 14 4.8 
Obstructive nephropathy 22 7.5 
Envenomation/poisoning 18 6.1 
Rhabdomyolysis 5 1.7 
TMA 1 .3 
Hepatorenal syndrome 9 3.1 
Drugs 31 10.5 
Blood loss 5 1.7 
Surgical 26 8.8 
Miscellaneous/idiopathic 32 10.9 
 
Stones were present in 4.0%. Majority patients (87.1%) 
were in RIFLE „Failure‟ category. Total cases of 
Poisoning /envenomation were 6.1%. Poisoning cases 
included wheat preservative pill taken as suicidal 
intent (1.0%),copper sulphate poisoning  (0.6 %), 
methanol poisoning (0.6%).Envenomation included 
snake bite  (3.0%)(Table 2). Altered consciousness 
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(33.5%) was the commonest clinical presentation 
(Table  3). Overall Glomerular etiology was found in 
4.8% (Table 4). Intermittent haemodialysis was 
performed in  33.3 %, whereas 9.9% could not be 
dialyzed because of hemodynamic instability. 
Conservative management was done in 45.9%. 
Mortality was 39.1%  reflecting critical condition and 
markedly deranged renal function on admission.  
 
Table  2: Assessment and outcome of patients 
Variables total no of patients=  294 Frequency Percent 
RIFLE 
Risk 1 .3 
Injury 37 12.6 
Failure 256 87.1 
Volume 
Hypovolemia 127 43.2 
Euvolemic 89 30.3 
Fluid overload 78 26.5 
Treatment 
Dialysis 98 33.3 
Conservative 135 45.9 
Not possible 29 9.9 
Refused 32 10.9 
Length of stay Mean=5.2823,  SD=3.80298, Min=1.00, Max= 21.00 
< 7 days 236 80.3 
7 - 14 days 43 14.6 
15 - 21 days 15 5.1 
Outcome   
Expired 115 39.1 
Alive 152 51.7 
LAMA 27 9.2 
 
Table   3: Sign and Symptoms Frequencies 
Multiple responses 
Symptoms                         cases 
Number Percent 
Fever 76 25.80% 
Altered LOC 91 30.90.% 
Jaundice 44 14.96% 
Hypotension 84 28.57% 
Hypertension 45 15.30% 
Oligoanuria 150 51.02% 
Acidosis 231 78.57% 
DIC 112 38.09% 
Sepsis 131 44.55% 
 
Table  4: Final Diagnosis Histopathology / renal 
biopsy (n=25) 
Final Diagnosis  
Histopathology/renal 
biopsy (n=25) 
Frequency Percentage 
Post infectious GN/MPGN 8 2.7% 
RPGN/Cresenteric GN 5 1.6% 
Collapsing FSGS/HIVAAN 1 0.3% 
AIN 3 1.0% 
ATN 2 0.6% 
Myeloma kidney 2 0.6% 
TMA/HUS 1 0.3% 
Cholesterol embolism 1 0.3% 
Primary lymphoma kidney 1 0.3% 
Inconclusive 1   0.3% 
 
Table 5: Acute Kidney Injury-Comparison with other studies 
 Current study 
Chaudhri 
et al 
Osman etal 
2012 
Reddyetal 
2014 
 
Peres et al 
2014 
 
Korula 
 et al 
2016 
Bhadade 
et al 
2016 
Halle et al 
2017 
 
Mehta et al 
2018 
Risk 0.3 % 24.2 % 25.3 % 26 % 20.9 % 8.5 % 32.8 % 41.7 % 
Injury 12.6 % 27.9 % 27.7  % 28 % 37.4 % 20.2 % 23.9 % 10.0 % 
Failure 87.0 % 47.9 % 46.9 % 46 % 41.7 % 71.2 % 43.3 % 48.2 % 
Sepsis 44.6 % 44.0 % 19.8 % 32 % 75.5 % 32 % 50.4 % 19.5% 
Mortality 39.1 % 31.2 % 30.1 % 35.9 % 49.5 % 51.9 % 36.9 % 12.1 % 
Tertiary Care 
Setting 
Nephrology 
unit 
All 
wards/ICU 
ICU ICU ICU ICU Med Ward/ICU Nephrology 
ward/ICU 
Total AKI  case 294 384 242 
 
81 115 316 536 230 
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Discussion 
In  present  study RIFLE category “risk”  was present 
in 0.3%, “injury” was present in 12.6%,whereas 
maximum number fell in  “failure” category 87.1%. 
Studies from India also substantiated these findings. 
(Table 6).15-17 Infection/Sepsis is the main contributing 
factor to AKI. In our study sepsis was the predominant 
factor for AKI accounting for 44.6%,whereas in studies 
from neighboring India it was present in  it ranges 
from 20.6% to 75.5% . 16-22 Studies from African 
countries showed sepsis in a range from 34.6 to 50%. 23-
29 From Pakistan Rabbani et al reported sepsis in 25.4% 
patients with acute kidney injury . 30  In present study 
acute febrile illness was seen mainly in July to October 
(summer/monsoon season). The establishment of 
etiological diagnosis was difficult in these cases . 
Present study showed drugs to be responsible  in 10.5 
% whereas other studies showed  variable statistics, 
i.e., from 2,.1% to 12.4%.21,22,25, 26,28, 31,32 In our study 
pre-renal AKI accounted for 29.6 % cases, Renal-AKI  
60.5 % and post-renal AKI  was present in 8.2 % and 
idiopathic 2.3 %. Another study from Pakistan, 
reported pre-renal AKI to be present in 70 %, renal-
AKI in 22 % and post-renal in 8%.30 In present study 
mortality was around 39.1 %. Other studies  showed 
mortality  from 8.7% to 36.9%. 16,17, 19,20, 24-26,30,33,34  
Another study from Pakistan reported mortality of 
34.0 % .30  
In present  study it was observed that our patients had 
high mortality because they had severe AKI on 
presentation.  Multiple factors like initially seeking 
alternative remedies and fallacies, poverty, lack of 
awareness, poor recognition of the condition, high cost 
of medical treatment, also play a role. Long distance 
from tertiary care hospitals, late presentation and late 
referrals, poor acceptability and limited availability for 
hemodialysis, high turnover of patients in public 
hospitals, inadequate laboratory support. Only routine 
laboratory tests are available in public hospitals, 
specialized serological tests for infectious and 
autoimmune diseases, glomerulonephritis/ vasculitis 
and renal biopsy are expensive and  usually 
expensive.Cost of medicines, nutrition, dialysis 
catheter and hemodialysis to be borne by patients in 
addition, loss of work/money (both patient and 
accompanying family members) incurred by hospital 
admission. The number of hospital bed and ICU beds 
were  inadequate, as well as CRRT(continuous renal 
replacement therapy)was not available for 
hemodynamically unstable patients making 
management of critical cases difficult. There is vital 
need for collecting epidemiological data of AKI and to 
establish a national registry. This can be translated in 
identifying magnitude of AKI and barriers to care .The 
review by Olowu et al reported   that in most sub-
Saharan Africa countries many hurdles to diagnosis 
and management of AKI exist, the most consistent of 
which are delays in reaching hospital, prohibitive cost 
of care, erratic functioning or supply of hospital 
resources, and female sex. 36  There is extreme shortage 
of trained health care workers in developing countries 
internationally. Statistics projected in 2007 showed that 
sub-Saharan Africa, accounting for 11%  earths 
population, endures 24% of the worldwide disease 
burden,  with only 3% of the global health workforce, 
and spends less than 1% of global  health 
expenditure.37  There is crucial need for health sector 
decentralization and establishing effective public 
health services in Pakistan with meager reaources.38 
International Society of Nephrology  set on the mission 
of eliminating preventable or treatable deaths from 
AKI by 2025, the “0 by 25” initiative.39  Establishing 
this program in these resource stricken  countries 
poses significant challenge. Also data regarding 
epidemiology and causes of AKI from these countries 
is scarce. 40 Role of non-governmental organizations in 
promoting political and social change is pivotal in 
developing communities and promoting citizen 
participation.  
Conclusion 
Acute kidney injury is a major public health challenge. 
Majority of our patients presented with severe 
AKI/RIFLE category Failure needing renal 
replacement therapy.AKI is associated with high 
morbidity and mortality. Infection/sepsis is the 
predominant etiological factor causing AKI in our 
patients.  
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